![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Gottlieb to Discuss Competition in Drug Markets at FTC Event
Gottlieb to Discuss Competition in Drug Markets at FTC Event
October 10, 2017
FDA Commissioner Scott Gottlieb will deliver a keynote address Nov. 8 at a public FTC workshop in Washington on competition in prescription drug markets.
The workshop will comprise two sessions: one on generic drug markets, including barriers to entry, and a second on pharmacy benefit managers, group purchasing organizations and other supply-chain intermediaries.
A theme of the workshop is encouraging competition and participation in the drug markets.
Upcoming Events
-
21Oct